Carl Zeiss Meditec | Sustainability Performance
Develops and markets medical devices and solutions for ophthalmology and microsurgery applications.
2002
Germany
5,001 - 10,000 employees
Medical Device
$1B - 10B in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#9191
Overall#424
in Germany#135
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and exclusionsFinancial Data
Business performanceCapital & innovationAnalyst projectionsAsset manager exclusion
Market cap
Revenue
R&D intensity
Controversy level
- Carl Zeiss Meditec AG, German major ophthalmology/microsurgery medical devices (Carl Zeiss Foundation 59% controlled, listed), has faced multiple US class actions over alleged inadequate disclosure of US/European ophthalmology customer demand normalization following the contested 2024 sustained share price volatility amid postCOVID ophthalmology customer demand normalization affecting German institutional shareholders amid global ophthalmology sector pressure.
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$2.5BFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
14.6%FY2025
R&D as % of revenue
R&D as % of revenue
Industry benchmark
Powered by illuminem
Return on invested capital
5.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
2.4
▲ 4.2%
2.3
▼ 0.2%
2.5
▲ 1.3%
2.7
2030Powered by illuminem
Exclusions by region
Reveal data for 2 credits
Institutions excluding by region out of total tracked institutions
Excluding institutions
Reveal data for 2 credits
Institution name, type, screener label
Powered by illuminem andEnvironmental policy coverage
Carbon reduction policy
Available
Human rights policy
Available
Recycling policy
Not available
Workplace health & safety policy
Available
7%
Independent Directors
1 out of 15 incl. management
SBTi targets and commitments
| Target | Status | Temperature alignment | Year |
|---|---|---|---|
| Near-term target | Targets set | 1.5°C | FY2030 |
| Long-term target | Not disclosed | - | - |
| Net-zero | Not disclosed | - | - |
| Business Ambition 1.5°C | Not disclosed | - | - |
Target details
Near-Term Targets: ZEISS commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by FY2030 from a FY2024 base year. ZEISS also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods and use of sold products 25.0% within the same timeframe. ZEISS further commits that 47.0% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by FY2030.
Powered by illuminem and Science Based Targets initiative. Last updated: 07 May 2026Overall score
85
Environment
99
Social
99
Governance
56
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
